Drug Development Tools Research Grants (U01) Clinical Trials Optional

Federal funding opportunity RFA-FD-24-030 from Food and Drug Administration (Department of Health and Human Services).

Program funding history

Synopsis

Who can apply

• County governments
• Native American tribal organizations (other than Federally recognized tribal governments)
• For profit organizations other than small businesses
• City or township governments
• Special district governments
• Independent school districts
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• Private institutions of higher education
• Native American tribal governments (Federally recognized)
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• State governments
• Public housing authorities/Indian housing authorities
• Public and State controlled institutions of higher education
• Small businesses

These grants will be used to provide funding to developers of drug development tools that have an accepted or a reviewable Letter of Intent (LOI) within a CDER/CBER's Drug Development Tool Qualification Program and are working towards their qualification plan (QP) or full qualification package (FQP).If you received DDT research grant support from FDA-CDER/CBER in previous years, you are eligible to apply provided that you have successfully progressed to the next submission milestone (e.g., Accepted LOI to Accepted QP) and are requesting additional funding for new DDT project needs addressing different aspects of the project.

The official record

Similar grants

• Integrating Machine Learning with Computational Fluid Dynamics Models of Orally Inhaled Drug Products (U01) Clinical Trials Not Allowed
  FOR-FD-24-001 · Food and Drug Administration
• Improving Predictability of Food-Drug and Drug-Drug Interaction Risks by Utilizing In Vitro Simulated Gastrointestinal Dissolution Model for High-Risk Oral Drug Products (U01) Clinical Trial Optional
  FOR-FD-24-005 · Food and Drug Administration
• Center for Research on Complex Generics (U18) Clinical Trials Optional
  FOR-FD-25-004 · Food and Drug Administration
• REACHing Communities (REACH) Consortium (U01) Clinical Trials Optional
  FOR-FD-25-012 · Food and Drug Administration
• Animal Food Regulatory Program Standards Implementation Development and Maintenance, with Mutual Reliance Initiatives Clinical Trials Not Allowed
  PAR-25-003 · Food and Drug Administration · closes April 1, 2027
• Developing PBPK Model-Based Mechanistic IVIVCs for Long Acting Injectable Suspensions and Implants (U01) Clinical Trial Optional
  FOR-FD-24-002 · Food and Drug Administration